Clinical trials: Respiratory Insufficiency of Prematurity

Hypoxic Respiratory Failure With Pulmonary Hypertension

Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure

• Withdrawn
• Age: Up to 48 hours
• Phase 3

This Phase 3, Double-blind, Randomized, Placebo controlled, multicenter study is to confirm the efficacy of inhaled nitric oxide for the management of hypoxic respiratory failure associated with pulmonary hypertension in preterm…

Trial name

NCT00922532

Testing

Inhaled Nitric Oxide

Sponsor

Mallinckrodt